ReShape Lifesciences Inc. (NASDAQ: RSLS) Stock Information | RedChip

ReShape Lifesciences Inc. (NASDAQ: RSLS) Listen to this Section


$0.18
+0.0011 ( +0.63% ) 506.2K

Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.

Market Data


Open


$0.18

Previous close


$0.18

Volume


506.2K

Market cap


$4.21M

Day range


$0.18 - $0.19

52 week range


$0.14 - $1.29

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 14 Oct 05, 2023
8-k 8K-related 14 Sep 22, 2023
10-q Quarterly Reports 59 Aug 07, 2023
8-k 8K-related 15 Aug 07, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.